U.S. Logistics Stock News

NYSE:MGM
NYSE:MGMHospitality

MGM Resorts (MGM) Faces $18 Billion Bid As Conflict Questions Grow

People Inc., led by Barry Diller, has proposed an $18 billion acquisition of MGM Resorts International (NYSE:MGM). The offer has drawn regulatory scrutiny from gaming authorities, including the Nevada Gaming Commission. Legal investigations are examining potential conflicts of interest and fiduciary duty issues related to Diller’s roles as MGM’s largest shareholder and board member. MGM Resorts International, trading at $45.54, is at the center of a high profile takeover proposal that could...
NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

The Bull Case For MannKind (MNKD) Could Change Following FDA Approval Of At-Home Furoscix ReadyFlow Autoinjector – Learn Why

MannKind Corporation recently announced that the U.S. FDA approved Furoscix ReadyFlow, an at-home autoinjector delivering IV-equivalent furosemide for treating edema in adults with heart failure or chronic kidney disease, with dosing completed in under 10 seconds. This approval opens a new at-home care option in a very costly disease area and may expand MannKind’s reach beyond hospital-based treatment. We’ll now explore how FDA approval of this rapid at-home Furoscix ReadyFlow autoinjector...
NasdaqGS:BFST
NasdaqGS:BFSTBanks

Will BFST’s Stronger Earnings and Capital Returns Shift Business First Bancshares' (BFST) Narrative?

Business First Bancshares, Inc. has reported past second-quarter 2026 results showing higher net interest income of US$77.84 million and net income of US$24.18 million year on year, while also declaring common and preferred dividends payable on August 31, 2026. The company’s completion of a US$11.29 million share repurchase program, alongside increased earnings and affirmed dividends, highlights management’s focus on returning capital to shareholders. We’ll now examine how Business First...
NasdaqGM:USAR
NasdaqGM:USARMetals and Mining

USA Rare Earth (USAR) Acquires 13.6% Of Carester To Deepen Its European Footprint

USA Rare Earth (NasdaqGM:USAR) has acquired a 13.6% stake in French rare earth processing company Carester SAS. The deal formalizes a supply chain collaboration focused on rare earth separation, midstream processing, and feedstock and oxide trading. The investment expands USA Rare Earth's position in the European rare earth value chain and connects its platform to Carester's processing facilities and engineering expertise. USA Rare Earth enters this agreement with Carester while its stock...
NYSE:O
NYSE:ORetail REITs

Realty Income (O) Stock Trades At A Premium On Earnings While 3 Year Returns Look Strong

Realty Income stock has delivered a 26.1% return over the past three years, yet its latest valuation checks lean on the expensive side, so investors are weighing a solid track record of returns against signals that the current price may already be baking in a lot of optimism. Over the past three years, Realty Income has returned 26.1%, which gives existing shareholders a reasonable gain to measure against today’s valuation. Recent moves to expand and recast the company’s credit facilities...
NYSE:KKR
NYSE:KKRCapital Markets

Is KKR’s Portfolio Reshuffle And Uncertain Earnings Outlook Altering The Investment Case For KKR (KKR)?

In recent days, KKR has weighed strategic options for KKR Real Estate Finance Trust and moved to exit its stake in LCY Chemical, while investors also look ahead to its late-July earnings report amid mixed analyst expectations. This combination of portfolio reshaping and an uncertain earnings outlook highlights how KKR is actively refining its business mix while facing questions about future profit resilience. Next, we’ll examine how KKR’s review of KKR Real Estate Finance Trust affects the...
NasdaqGS:NCMI
NasdaqGS:NCMIMedia

Streaming Stocks Retail Investors May Revisit After The Paramount Warner Bros Deal Pause

The paused US$110b merger between Paramount and Warner Bros Discovery has frozen a major shake up in streaming and content distribution, keeping current competitive lines in place for now. For investors, that pause can matter as much as the deal itself, because it helps reveal which stocks look more insulated and which remain heavily exposed to potential shifts in studio power and content supply. This article looks at 3 stocks from a Content Distribution and Streaming Platforms screener that...
NYSE:HASI
NYSE:HASIDiversified Financial

Is HASI’s Larger, Cheaper Sustainability-Linked Credit Refinancing Altering The Investment Case For HA Sustainable Infrastructure Capital (HASI)?

Earlier this month, HA Sustainable Infrastructure Capital, Inc. entered into a new US$2.25 billion, 5-year unsecured revolving credit facility and a US$400 million, 3-year senior unsecured term loan, both tied to CarbonCount-based sustainability metrics and replacing prior facilities. The refinancing not only increases total committed liquidity but also lowers interest spreads, signaling lender confidence in the company’s climate-focused infrastructure financing model and carbon performance...
NYSE:VICI
NYSE:VICISpecialized REITs

VICI Properties (VICI) Heads Into Earnings, Is The Stock Still Trading At A Discount?

VICI Properties (VICI) drew fresh attention after the stock gained 1.56% in the latest session, ahead of its July 29, 2026 earnings release. See our latest analysis for VICI Properties. At a share price of $26.73, VICI Properties has seen short term momentum soften, with the share price return down 5.9% over three months and the 1 year total shareholder return declining 14.7%. This may reflect shifting expectations for risk and income relative to other real estate investment options. If this...
NYSE:UNH
NYSE:UNHHealthcare

UnitedHealth Group (UNH) Following Earnings Beat And Buybacks Is The Stock Fully Valued

UnitedHealth Group (UNH) has reported new earnings, with second quarter 2026 results and an active share repurchase program giving investors updated figures to assess the health care giant’s stock. See our latest analysis for UnitedHealth Group. UnitedHealth Group’s recent earnings beat, share repurchases and raised full year outlook come against a backdrop of strong momentum, with a 90 day share price return of 18.55% and a 1 year total shareholder return of 53.71%, even though the 3 year...
NYSE:COMP
NYSE:COMPReal Estate

Compass (COMP) On Housing Optimism And Upgrades, The Undervalued Case Gets Another Look

Renewed housing optimism puts Compass stock in focus Renewed optimism about the housing market and recent analyst upgrades have put Compass (COMP) back on investors’ radar, with the stock now attracting attention for both its strong past returns and richer valuation. See our latest analysis for Compass. After a recent pullback that left the 7 day share price return down 7.75%, Compass is still up 41.02% on a 90 day share price basis and has delivered a 53.32% 1 year total shareholder return...
NYSE:AAP
NYSE:AAPSpecialty Retail

Is Advance Auto Parts (AAP) Fully Priced After Fresh Hopes For Another Earnings Beat?

Advance Auto Parts (AAP) recently filed an omnibus shelf registration covering debt, common and preferred stock, depositary shares, warrants and units, giving the company flexibility to raise capital alongside growing interest in its earnings track record. See our latest analysis for Advance Auto Parts. At a share price of $55.80, Advance Auto Parts has seen a 4.5% 1 day and 5.0% 7 day share price return, while its 30 day and 90 day share price returns have slipped, and longer term total...
NYSE:T
NYSE:TTelecom

AT&T (T) Is Up 10.6% After Raising 2026 Buyback Target On Q2 Earnings Beat

In the past week, AT&T reported Q2 2026 results showing revenues of US$31,558 million and net income of US$4,627 million, with earnings per share rising to US$0.66 from US$0.62 a year earlier. Alongside an earnings beat and strong growth in Advanced Connectivity customers, AT&T lifted its 2026 share repurchase target to about US$10 billion, underscoring management’s confidence in cash generation and the fiber‑plus‑5G convergence strategy. Next, we’ll examine how AT&T’s stronger-than-expected...
NasdaqGS:OSIS
NasdaqGS:OSISElectronic

OSI Systems (OSIS) Draws Earnings Beat Attention, Is The Stock Still A Bargain?

Recent commentary around OSI Systems (OSIS) centers on its history of outperforming earnings estimates, with a positive Earnings ESP and favorable Zacks Rank raising expectations for another potential surprise in the upcoming quarterly report. See our latest analysis for OSI Systems. At a recent share price of US$216.70, OSI Systems has seen modest positive short term momentum, including a 7 day share price return of 1.90%. However, the 90 day share price return is down 25.94%, while the 3...
NYSE:KWR
NYSE:KWRChemicals

Quaker Chemical (KWR) Could Be 11% Undervalued Following Cautious Earnings Expectations

Quaker Chemical (KWR) heads into its upcoming earnings release with expectations for a year over year decline in quarterly profit, even as revenue is projected to be higher and sentiment has turned more cautious. See our latest analysis for Quaker Chemical. Quaker Chemical's share price has climbed 8.97% year to date to US$151.43, with a 7.52% 90 day share price return and a 25.80% total shareholder return over one year. However, longer term total shareholder returns over three and five years...
NYSE:WST
NYSE:WSTLife Sciences

West Pharmaceutical Services (WST) Stock Sees Margin Improvement Narrative Backed By Q2 2026 Results

West Pharmaceutical Services (WST) has just posted Q2 2026 results with revenue of US$872.3 million, basic EPS of US$2.18 and net income of US$154 million, setting the tone for how investors assess its current profitability. The company has seen quarterly revenue move from US$766.5 million in Q2 2025 to US$872.3 million in Q2 2026, while basic EPS shifted over the same period from US$1.83 to US$2.18, giving investors a clear view of how the top line and per share earnings have tracked...
NYSE:CNC
NYSE:CNCHealthcare

Centene (CNC) Stock Looks Below Fair Value While Its 123% Gain Tests Upside

Centene stock has delivered a strong 1 year return while the current valuation checks still point to the shares screening as undervalued on several metrics. This raises the question of how much of that gain is already reflected in the current US$63.41 price. Over the last 1 year, Centene is up 123.4%, which puts recent buyers in profit and makes the current valuation more important for anyone considering new capital. Future growth in membership and medical cost control can support earnings,...
NasdaqGM:NUAI
NasdaqGM:NUAIOil and Gas

Is New Era Energy & Digital (NUAI) A Bargain On Law Firm Investigation Concerns?

New Era Energy & Digital (NUAI) is under scrutiny after law firm Bronstein, Gewirtz & Grossman, LLC announced an investigation into potential corporate wrongdoing involving the company and certain officers or directors. See our latest analysis for New Era Energy & Digital. The latest law firm investigation comes after a sharp pullback in New Era Energy & Digital's share price, which fell about 10% in the last session. This followed a 7 day share price return of around 17% and a year to date...
NYSE:ATI
NYSE:ATIAerospace & Defense

ATI (ATI) Could Be 1% Below Fair Value On Earnings Growth Hopes

ATI (ATI) stock recently gained 2.17% on a weak market day, as investors focused on expectations for significant year-over-year earnings growth ahead of the company’s August 6, 2026 report. See our latest analysis for ATI. Zooming out, ATI’s recent move comes after a 90 day share price return of 28.23% and a year to date share price return of 65.94%. The 1 year total shareholder return stands at 108.23%, suggesting momentum has been building over both shorter and longer horizons. If ATI’s...
NYSE:NEM
NYSE:NEMMetals and Mining

Newmont (NEM) Posts Higher Sales And Income, Is The Discount To Fair Value Warranted?

Newmont stock reacts to mixed production and earnings update Newmont (NEM) has given investors a fresh data point to assess, reporting second quarter 2026 results that combine lower gold production with higher sales, higher net income, an ongoing buyback and a maintained dividend. See our latest analysis for Newmont. At a share price of $93.19, Newmont has risen strongly on a 1 year total shareholder return of 43.24%, even though the 90 day share price return is down 22.79%. This points to...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Atlassian (TEAM) Could Be 4% Overvalued Following Its AI Driven Jira Rollout

AI driven Jira upgrades put Atlassian (TEAM) in focus Atlassian (TEAM) is drawing fresh attention after launching new AI powered Jira capabilities aimed at common software development bottlenecks, from planning and review to cross team workflows and cost tracking. See our latest analysis for Atlassian. Atlassian’s AI driven Jira release lands after a sharp 1 day share price gain of 8.4% to US$86.88, although the stock’s year to date share price return is down 43.86% and the 1 year total...
NasdaqGM:ASST
NasdaqGM:ASSTMedical Equipment

Strive (ASST) Stock May Be Undervalued As Profitability Questions Persist

Strive’s share price has fallen sharply in recent years, yet the stock still screens as undervalued on market multiples while its broader valuation checks remain weak. This leaves investors with a mixed message on what the current price really offers. Strive has declined about 90% over the past 3 years, which signals that the market has heavily reset expectations for the business. Any improvement in Strive’s ability to turn revenue into consistent cash flow can help support the current...
NasdaqGS:EXLS
NasdaqGS:EXLSProfessional Services

Does ExlService’s New Governance Bench Signal a Deeper Shift in Its AI Strategy Narrative (EXLS)?

ExlService Holdings, Inc. recently appointed Bina Mehta, former Chair of KPMG UK, to its Board as an independent director and announced that Sarah K. Williamson will become lead independent director by the end of 2026, while Vikram Pandit remains on the Board. The addition of Mehta to the audit and compensation and talent management committees, alongside Williamson’s board leadership transition, points to an increased emphasis on governance, risk oversight, and talent-focused decision-making...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

TG Therapeutics (TGTX) Stock Looks Below Fair Value on Earnings

TG Therapeutics has delivered a strong share price run over the past three years, yet the stock still screens as undervalued on earnings-based multiples and only a mixed verdict on the broader valuation checks. Over the past three years, TG Therapeutics has returned 184.5% to shareholders, which puts extra focus on whether the current valuation leaves enough room for error. Future revenue growth from its existing treatments can support the current price. However, execution risks around...